Clustering of ABCB1 and CYP2C19 Genetic Variants Predicts Risk of Major Bleeding and Thrombotic Events in Elderly Patients with Acute Coronary Syndrome Receiving Dual Antiplatelet Therapy with Aspirin and Clopidogrel

被引：0
|
作者：
Roberta Galeazzi
Fabiola Olivieri
Liana Spazzafumo
Giuseppina Rose
Alberto Montesanto
Simona Giovagnetti
Sara Cecchini
Gelsomina Malatesta
Raffaele Di Pillo
Roberto Antonicelli
机构：
[1] INRCA National Institute,Clinical Laboratory and Molecular Diagnostics
[2] DISCLIMO,Department of Clinical and Molecular Sciences
[3] Università Politecnica delle Marche,Center of Clinical Pathology and Innovative Therapy
[4] INRCA National Institute,Center of Biostatistics
[5] INRCA National Institute,Department of Biology, Ecology and Earth Sciences
[6] University of Calabria,Unit of Radiology
[7] National Institute of Health and Science on Aging (INRCA),Cardiology Unit
[8] National Institute of Health and Science on Aging (INRCA),undefined
来源：
Drugs & Aging | 2018年 / 35卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：649 / 656
页数：7
相关论文
共 50 条
  • [41] Diabetes and CYP2C19 Polymorphism Synergistically Impair the Antiplatelet Activity of Clopidogrel Compared With Ticagrelor in Percutaneous Coronary Intervention-treated Acute Coronary Syndrome Patients
    Mohareb, Mina W.
    AbdElghany, Mohamed
    Zaki, Hala F.
    El-Abhar, Hanan S.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2020, 76 (04) : 478 - 488
  • [42] Do CYP2C19 and ABCB1 gene polymorphisms and low CYP3A4 isoenzyme activity have an impact on stent implantation complications in acute coronary syndrome patients?
    Rytkin, Eric
    Mirzaev, Karin B.
    Grishina, Elena A.
    Smirnov, Valeriy V.
    Ryzhikova, Kristina A.
    Sozaeva, Zhannet A.
    Giliarov, Michael Iu
    Andreev, Denis A.
    Sychev, Dmitriy A.
    PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2017, 10 : 243 - 245
  • [43] Risk of major adverse cardiovascular events of CYP2C19 loss-of-function genotype guided prasugrel/ticagrelor vs clopidogrel therapy for acute coronary syndrome patients undergoing percutaneous coronary intervention: a meta-analysis
    Biswas, Mohitosh
    Kali, Most. Sumaiya Khatun
    Biswas, Tapash Kumar
    Ibrahim, Baharudin
    PLATELETS, 2021, 32 (05) : 591 - 600
  • [44] UNIVERSAL CLOPIDOGREL VERSUS CYP2C19-GUIDED ANTIPLATELET THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME - A COST-EFFECTIVENESS ANALYSIS
    Jiang, M.
    You, J.
    VALUE IN HEALTH, 2015, 18 (03) : A19 - A19
  • [45] INFLUENCE OF THE CYP3A4 ISOENZYME METABOLIC ACTIVITY AND CYP2C19 GENE POLYMORPHISMS ON CLOPIDOGREL ANTIPLATELET EFFECT IN PATIENTS WITH ACUTE CORONARY SYNDROME UNDERGOING PERCUTANEOUS CORONARY INTERVENTION
    Mirzaev, K. B.
    Kazakov, R. E.
    Smirnov, V. V.
    Andreev, D. A.
    Sychev, D. A.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2015, 11 (04) : 344 - 354
  • [46] CYP2C19 phenotype in South-East Asian Acute Coronary Syndrome patients and impact on major adverse cardiovascular events
    Tan, Doreen Su-Yin
    Aw, Jernice Wan Xin
    Winther, Michael
    Goh, Liuh Ling
    Ong, Hean Yee
    Wee, Eric
    Liu, Jianjun
    Ho, Han Kiat
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2020, 45 (01) : 52 - 58
  • [47] Polymorphism on CYP2C19 genes, diabetes and smoker status affect the response to Clopidogrel therapy among Asian patients with acute coronary syndrome
    Rumenta, D.
    Sukmawan, R.
    Dharma, R.
    Henrika, F.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2018, 20 (0D) : D22 - D22
  • [48] Frequency of CYP3A4, CYP3A5, CYP2C9, and CYP2C19 variant alleles in patients receiving clopidogrel that experience repeat acute coronary syndrome
    Marcia L. Brackbill
    Robert S. Kidd
    April D. Abdoo
    James G. Warner
    Arthur F. Harralson
    Heart and Vessels, 2009, 24 : 73 - 78
  • [49] A Pharmacogenetic Study of CYP2C19 in Acute Coronary Syndrome Patients of Colombian Origin Reveals New Polymorphisms Potentially Related to Clopidogrel Therapy
    Angulo-Aguado, Mariana
    Panche, Karen
    Andrea Tamayo-Agudelo, Caroll
    Ruiz-Torres, Daniel-Armando
    Sambracos-Parrado, Santiago
    Jose Nino-Orrego, Maria
    Paez, Nathaly
    Pineros-Hernandez, Laura B.
    Castillo-Leon, Luisa-Fernanda
    Mauricio Pardo-Oviedo, Juan
    Parra Abaunza, Katherine
    Laissue, Paul
    Contreras, Nora
    Alberto Calderon-Ospina, Carlos
    Janeth Fonseca-Mendoza, Dora
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (05):
  • [50] Frequency of CYP3A4, CYP3A5, CYP2C9, and CYP2C19 variant alleles in patients receiving clopidogrel that experience repeat acute coronary syndrome
    Brackbill, Marcia L.
    Kidd, Robert S.
    Abdoo, April D.
    Warner, James G., Jr.
    Harralson, Arthur F.
    HEART AND VESSELS, 2009, 24 (02) : 73 - 78
12345